Cohance Lifesciences Limited (NSE:COHANCE)
1,064.90
-5.75 (-0.54%)
Jul 22, 2025, 3:30 PM IST
Cohance Lifesciences Revenue
In the fiscal year ending March 31, 2025, Cohance Lifesciences had annual revenue of 11.98B INR with 13.91% growth. Cohance Lifesciences had revenue of 4.02B in the quarter ending March 31, 2025, with 58.94% growth.
Revenue
11.98B
Revenue Growth
+13.91%
P/S Ratio
34.20
Revenue / Employee
10.04M
Employees
1,193
Market Cap
409.60B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Glenmark Pharmaceuticals | 134.35B |